0000084129 false 0000084129 2021-07-07 2021-07-07 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of report (Date of earliest event reported): July 7, 2021

 

Rite Aid Corporation

(Exact name of registrant as specified in its charter)

 

Delaware   1-5742   23-1614034
(State or Other Jurisdiction
of Incorporation)		   (Commission File Number)   (IRS Employer
Identification Number)

 

30 Hunter Lane, Camp Hill, Pennsylvania 17011

(Address of principal executive offices, including zip code)

 

(717) 761-2633

(Registrant’s telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which
registered
Common Stock, $1.00 par value   RAD   The New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company      ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.      ¨

  

 

 

 

 

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

At the 2021 Annual Meeting of Stockholders (the “Annual Meeting”) of Rite Aid Corporation (“Rite Aid”) held on July 7, 2021, the stockholders of Rite Aid approved an amendment and restatement of the Rite Aid Corporation 2020 Omnibus Equity Incentive Plan (the “2020 Plan,” and as amended and restated, the “Amended and Restated 2020 Plan”) to increase by 2,700,000 shares the number of shares of Rite Aid’s common stock reserved for issuance under the 2020 Plan.

 

A summary of the material terms of the Amended and Restated 2020 Plan was included in Rite Aid’s definitive proxy statement filed with the Securities and Exchange Commission on May 20, 2021 (the “Definitive Proxy Statement”) in connection with the Annual Meeting, under the section entitled “Proposal No. 4—Approval of the Rite Aid Corporation Amended and Restated 2020 Omnibus Equity Incentive Plan” beginning on page 78 of the Definitive Proxy Statement. The summary of the Amended and Restated 2020 Plan in the Definitive Proxy Statement is qualified in its entirety by reference to the full text of the Amended and Restated 2020 Plan, which is attached hereto as Exhibit 10.1 and is incorporated herein by reference.

 

Item 5.07. Submission of Matters to a Vote of Security Holders.

 

The following is a summary of the matters voted on at the Annual Meeting.

 

(a)The stockholders elected Rite Aid’s nominees to the Board of Directors. The persons elected to Rite Aid’s Board of Directors and the number of shares cast for, the number against, the number abstaining and broker non-votes, with respect to each of these persons, were as follows:

 

Name  For   Against   Abstain   Broker Non-Votes 
Bruce G. Bodaken   22,648,437    4,127,743    161,763    14,229,522 
Elizabeth “Busy” Burr   24,215,599    2,357,841    364,503    14,229,522 
Heyward Donigan   24,438,294    2,187,040    312,609    14,229,522 
Bari Harlam   24,177,020    2,393,971    366,952    14,229,522 
Robert E. Knowling, Jr.   23,798,470    2,759,738    379,735    14,229,522 
Kevin E. Lofton   22,809,958    3,959,222    168,763    14,229,522 
Louis P. Miramontes   23,946,747    2,587,523    403,673    14,229,522 
Arun Nayar   24,247,702    2,296,765    393,476    14,229,522 
Kate B. Quinn   24,193,683    2,396,556    347,704    14,229,522 

 

(b)The stockholders ratified the appointment of Deloitte & Touche LLP as Rite Aid’s independent registered public accounting firm. The number of shares cast in favor of the ratification of Deloitte & Touche LLP, the number against, the number abstaining and broker non-votes were as follows:

 

For   Against   Abstain   Broker Non-Votes 
 37,862,140    2,679,058    626,267    0 

 

 

 

 

(c)The stockholders approved, on an advisory basis, the compensation of Rite Aid’s Named Executive Officers as set forth in the Definitive Proxy Statement. The number of shares cast in favor of the compensation of Rite Aid’s Named Executive Officers, the number against, the number abstaining and broker non-votes were as follows:

 

For   Against   Abstain   Broker Non-Votes 
 22,281,448    4,217,916    438,579    14,229,522 

 

(d)The stockholders approved the Amended and Restated 2020 Plan as set forth in the Definitive Proxy Statement. The number of shares cast in favor of the adoption of the Amended and Restated 2020 Plan, the number against, the number abstaining and broker non-votes were as follows:

 

For   Against   Abstain   Broker Non-Votes 
 21,156,066    5,398,827    383,050    14,229,522 

 

(e)The stockholders did not approve a stockholder proposal, introduced from the floor by Mr. Steven Krol, requesting the Board of Directors report in the annual proxy statement on Rite Aid’s latest J.D. Power customer satisfaction ranking (or equally respected independent source) and steps to be implemented if Rite Aid is not ranked in the top two brick and mortar pharmacies. The number of shares cast in favor of the stockholder proposal, the number against, the number abstaining and broker non-votes were as follows:

 

For   Against   Abstain   Broker Non-Votes 
 45,764    26,892,179    0    14,229,522 

 

Item 9.01. Financial Statements and Exhibits.

 

(d)       Exhibits.

 

10.1Rite Aid Corporation Amended and Restated 2020 Omnibus Equity Incentive Plan (incorporated by reference to Appendix B to Rite Aid’s Definitive Proxy Statement on Schedule 14A, filed on May 20, 2021).
104Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  RITE AID CORPORATION
       
Dated: July 9, 2021 By: /s/ Matthew C. Schroeder
    Name: Matthew C. Schroeder
    Title: Executive Vice President and Chief Financial Officer